83 results on '"Fiorentino, Michelangelo"'
Search Results
2. Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
3. Abstract 737: Variation in prognostic value of Gleason score for lethal prostate cancer using time-varying area under the curve
4. Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
5. Data from Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions
6. Supplementary Figure 1 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
7. Supplementary Figure 4 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
8. Supplementary Tables 1-12, Supplementary Figures 1-2 from The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
9. Supplementary Figure 2 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
10. Supplementary Table and Figure Legends from The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
11. Supplementary Figure 3 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
12. Data from The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
13. Supplementary Tables 1-5, Supplementary Figures 1-3 from Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions
14. Supplementary Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
15. Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
16. Supplementary Table 1 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
17. Supplementary Figure 3 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
18. Supplementary Table 4 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
19. Supplementary Figure 1 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
20. Supplementary Figure 2 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
21. Supplementary Table 3 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
22. Supplementary Table 3 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
23. Data from Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
24. Supplementary Table 1 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
25. Data from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
26. Supplementary Data from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
27. Supplementary Figure 1 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
28. Supplementary Table 2 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
29. Supplementary Tables 1, 2, 4 and 5 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
30. Data from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
31. Supplementary Table S1 from Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
32. Supplementary figure legend from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
33. Supplementary Figure 4 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
34. Supplementary Figure 1 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
35. The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
36. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions
37. AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
38. Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
39. Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer
40. A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer
41. Abstract B045: Gene expression pathways associated with vigorous physical activity in prostate cancer
42. Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer
43. Perineural Invasion and Risk of Lethal Prostate Cancer
44. Prognostic Utility of a New mRNA Expression Signature of Gleason Score
45. Abstract 1763: Body size and incidence of TMPRSS2:ERG fusion-positive and fusion-negative prostate cancer
46. MET DNA Alterations in NSCLC—Letter
47. Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
48. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer
49. SPINK1 Protein Expression and Prostate Cancer Progression
50. Prostate-Specific Membrane Antigen Protein Expression in Tumor Tissue and Risk of Lethal Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.